Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study

Digestive and Liver Disease

Volumn 45, Issue 5, 2013, Pages 377-384

  Malamut, Georgia ^a,b,c   Chandesris, Olivia ^a,d   Verkarre, Virginie ^a,c,d   Meresse, Bertrand ^a,c   Callens, Céline ^a,d   Macintyre, Elizabeth ^a,d   Bouhnik, Yoram ^e   Gornet, Jean Marc ^f   Allez, Matthieu ^f   Jian, Raymond ^a,b   Berger, Anne ^a,b   Châtellier, Gilles ^a,b   Brousse, Nicole ^a,c,d   Hermine, Olivier ^a,d   Cerf Bensussan, Nadine ^a,c   Cellier, Christophe ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e BEAUJON HOSPITAL   (France)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

Celiac disease; Enteropathy associated T cell lymphoma (EATL); Intraepithelial lymphocytes; Refractory celiac disease; Serum albumin; Surgery

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; SERUM ALBUMIN; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CELIAC DISEASE; CLINICAL ARTICLE; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION; INTESTINE MUCOSA; LYMPHOMA; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONITIS; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOSIS; TREATMENT RESPONSE;

ADULT; AGED; CAUSE OF DEATH; CELIAC DISEASE; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84876735207     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.12.001     Document Type: Article

References (33)

1. Novakovic B.J., Novakovic S., Frkovic-Grazio S. A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas. Oncology Reports 2006, 16:191-195.
2. Egan L.J., Walsh S.V., Stevens F.M., et al. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. Journal of Clinical Gastroenterology 1995, 21:123-129.
3. Daum S., Ullrich R., Heise W., et al. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German study group on intestinal non-Hodgkin's lymphoma. Journal of Clinical Oncology 2003, 21:2740-2746.
4. Gale J., Simmonds P.D., Mead G.M., et al. Enteropathy-type intestinal t-cell lymphoma: clinical features and treatment of 31 patients in a single center. Journal of Clinical Oncology 2000, 18:795-803.
5. Cellier C., Delabesse E., Helmer C., et al. Refractory sprue, coeliac disease, and enteropathy-associated t-cell lymphoma. French coeliac disease study group. Lancet 2000, 356:203-208.
6. Ekstrom Smedby K., Vajdic C.M., Falster M., et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the interlymph consortium. Blood 2008, 111:4029-4038.
7. Delabie J., Holte H., Vose J.M., et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 2011, 118:148-155.
8. Al-Toma A., Verbeek W.H., Hadithi M., et al. Survival in refractory coeliac disease and enteropathy associated T cell lymphoma: retrospective evaluation of single centre experience. Gut 2007, 56:1373-1378.
9. Malamut G., Afchain P., Verkarre V., et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009, 136:81-90.
10. Rubio-Tapia A., Kelly D.G., Lahr B.D., et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 2009, 136:99-107.
11. Alexandre J., Gross-Goupil M., Falissard B., et al. Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Annals of Oncology 2003, 14:36-41.
12. Sieniawski M., Angamuthu N., Boyd K., et al. Evaluation of enteropathy-associated t-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood 2010, 115:3664-3670.
13. Jabado N., Le Deist F., Cant A., et al. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Pediatrics 1996, 98/53:420-428.
14. Cellier C., Cuillerier E., Patey-Mariaud de Serre N., et al. Push enteroscopy in celiac sprue and refractory sprue. Gastrointestinal Endoscopy 1999, 50:613-617.
15. Oberhuber G., Granditsch G., Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. European Journal of Gastroenterology and Hepatology 1999, 11:1185-1194.
16. Marsh M. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 1992, 102:330-354.
17. Verkarre V., Asnafi V., Lecomte T., et al. Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut 2003, 52:205-211.
18. Kutlu T., Brousse N., Rambaud C., et al. Numbers of T cell receptor (TCR) alpha beta+ but not of TCR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut 1993, 34:208-214.
19. Cellier C., Patey N., Mauvieux L., et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998, 114:471-481.
20. Chott A., Dragosics B., Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. American Journal of Pathology 1992, 141:1361-2171.
21. Domizio P., Owen R.A., Shepherd N.A., et al. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. American Journal of Surgical Pathology 1993, 17:429-442.
22. Deleeuw R.J., Zettl A., Klinker E., et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 2007, 132:1902-1911.
23. Isaacson P.G., Chott A., Ott G., et al. Enteropathy-associated t-cell lymphoma. World Health Organisation classification of tumors Pathology and genetics of tumors of haematipoietic and lymphoid tissues 2008, 289-291. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
24. Musshoff K., Schmidt-Vollmer H. Proceedings: Prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification. Zeitschrift fur Krebsforschung und Klinische Onkologie. Cancer Research and Clinical Oncology 1975, 8:323-341.
25. Chott A., Haedicke W., Mosberger I., et al. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. American Journal of Pathology 1998, 153:1483-1490.
26. Spencer J., Cerf-Bensussan N., Jarry A., et al. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. American Journal of Pathology 1988, 132:1-5.
27. Cerf-Bensussan N., Begue B., Gagnon J., et al. The human intraepithelial lymphocyte marker hml-1 is an integrin consisting of a beta 7 subunit associated with a distinctive alpha chain. European Journal of Immunology 1992, 22:885.
28. Cepek K.L., Shaw S.K., Parker C.M., et al. Adhesion between epithelial cells and t lymphocytes mediated by e-cadherin and the alpha e beta 7 integrin. Nature 1994, 372:190-193.
29. Hoffmann M., Vogelsang H., Kletter K., et al. 18f-fluoro-deoxy-glucose positron emission tomography (18f-fdg-pet) for assessment of enteropathy-type T cell lymphoma. Gut 2003, 52:347-351.
30. Verkarre V., Romana S.P., Cellier C., et al. Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology 2003, 125:40-46.
31. Ansell S.M., Armitage J. Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clinic Proceedings 2005, 80:1087-1097.
32. Bristow R.E., Tomacruz R.S., Armstrong D.K., et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. Journal of Clinical Oncology 2002, 20:1248-1259.
33. Rini B.I. Metastatic renal cell carcinoma: many treatment options, one patient. Journal of Clinical Oncology 2009, 27:3225-3234.